CN108690029A - One kind is with optical activation to adjoin double loop coil oxidized indole compounds and its application - Google Patents
One kind is with optical activation to adjoin double loop coil oxidized indole compounds and its application Download PDFInfo
- Publication number
- CN108690029A CN108690029A CN201810391499.1A CN201810391499A CN108690029A CN 108690029 A CN108690029 A CN 108690029A CN 201810391499 A CN201810391499 A CN 201810391499A CN 108690029 A CN108690029 A CN 108690029A
- Authority
- CN
- China
- Prior art keywords
- loop coil
- double loop
- phenyl
- methyl
- independently selected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003287 optical effect Effects 0.000 title claims abstract description 30
- 230000004913 activation Effects 0.000 title claims abstract description 26
- 150000002475 indoles Chemical class 0.000 title claims abstract description 26
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 7
- 230000000259 anti-tumor effect Effects 0.000 claims abstract description 4
- 125000001424 substituent group Chemical group 0.000 claims abstract description 3
- -1 OBn Chemical group 0.000 claims description 47
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 25
- 229910052731 fluorine Inorganic materials 0.000 claims description 16
- 239000011737 fluorine Chemical group 0.000 claims description 16
- 239000000460 chlorine Substances 0.000 claims description 13
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 11
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 10
- 229910052794 bromium Inorganic materials 0.000 claims description 10
- 229910052801 chlorine Inorganic materials 0.000 claims description 9
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 8
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 8
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims description 6
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 6
- 125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 6
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 abstract description 12
- 238000003786 synthesis reaction Methods 0.000 abstract description 8
- 206010058467 Lung neoplasm malignant Diseases 0.000 abstract description 5
- 230000002401 inhibitory effect Effects 0.000 abstract description 4
- 201000005202 lung cancer Diseases 0.000 abstract description 4
- 208000020816 lung neoplasm Diseases 0.000 abstract description 4
- 206010006187 Breast cancer Diseases 0.000 abstract description 2
- 208000026310 Breast neoplasm Diseases 0.000 abstract description 2
- 239000007787 solid Substances 0.000 abstract description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 116
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 87
- 238000006243 chemical reaction Methods 0.000 description 81
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 58
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 58
- 239000000203 mixture Substances 0.000 description 58
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 41
- QNLOWBMKUIXCOW-UHFFFAOYSA-N indol-2-one Chemical compound C1=CC=CC2=NC(=O)C=C21 QNLOWBMKUIXCOW-UHFFFAOYSA-N 0.000 description 34
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 32
- 238000003756 stirring Methods 0.000 description 31
- PIIQLZXRLGJEKE-UHFFFAOYSA-N Cinchonicine Natural products C=CC1CNCCC1CCC(=O)C1=CC=NC2=CC=CC=C12 PIIQLZXRLGJEKE-UHFFFAOYSA-N 0.000 description 30
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 29
- 238000005160 1H NMR spectroscopy Methods 0.000 description 29
- 238000007445 Chromatographic isolation Methods 0.000 description 29
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 29
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 29
- 238000004587 chromatography analysis Methods 0.000 description 29
- 238000011097 chromatography purification Methods 0.000 description 29
- 238000004128 high performance liquid chromatography Methods 0.000 description 29
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 29
- 239000002585 base Substances 0.000 description 27
- 230000003647 oxidation Effects 0.000 description 24
- 238000007254 oxidation reaction Methods 0.000 description 24
- ZHQFLHOFPHEPSX-UHFFFAOYSA-N N1CCC2=CC=CC=C12.ClCCl Chemical compound N1CCC2=CC=CC=C12.ClCCl ZHQFLHOFPHEPSX-UHFFFAOYSA-N 0.000 description 23
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
- 238000012512 characterization method Methods 0.000 description 13
- 125000001246 bromo group Chemical group Br* 0.000 description 10
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 10
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 8
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical class C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 6
- JXDYKVIHCLTXOP-UHFFFAOYSA-N isatin Chemical compound C1=CC=C2C(=O)C(=O)NC2=C1 JXDYKVIHCLTXOP-UHFFFAOYSA-N 0.000 description 6
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 238000006735 epoxidation reaction Methods 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 3
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 229930192474 thiophene Natural products 0.000 description 3
- 125000001088 1-naphthoyl group Chemical group C1(=CC=CC2=CC=CC=C12)C(=O)* 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- LPIQUOYDBNQMRZ-UHFFFAOYSA-N cyclopentene Chemical compound C1CC=CC1 LPIQUOYDBNQMRZ-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 2
- 201000007270 liver cancer Diseases 0.000 description 2
- 208000014018 liver neoplasm Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 1
- 241001614291 Anoplistes Species 0.000 description 1
- 239000002879 Lewis base Substances 0.000 description 1
- JEYWNNAZDLFBFF-UHFFFAOYSA-N Nafoxidine Chemical compound C1CC2=CC(OC)=CC=C2C(C=2C=CC(OCCN3CCCC3)=CC=2)=C1C1=CC=CC=C1 JEYWNNAZDLFBFF-UHFFFAOYSA-N 0.000 description 1
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 238000010523 cascade reaction Methods 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 150000002240 furans Chemical class 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 150000007527 lewis bases Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000005296 lung carcinoma Diseases 0.000 description 1
- 229950002366 nafoxidine Drugs 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Indole Compounds (AREA)
Abstract
Disclosed in the present application to be that one kind in organic synthesis field is with optical activation adjoin double loop coil oxidized indole compounds, has the following structure:In formula:X is NR5, O or S substituent groups.The compound is white or faint yellow solid, has the characteristics that thermodynamic stability, optics Chun Du≤85%;The compound of the application has antitumor activity, such as has certain inhibiting effect to human hepatocellular, lung cancer and breast cancer cell.
Description
Technical field
The present invention relates to organic synthesis fields, and more specifically, the present invention, which is that one kind is with optical activation, adjoins double loop coils
Oxidized indole compounds and its application.
Background technology
Loop coil Oxoindole is to constitute many pharmaceutical activity molecules and day as a kind of particularly important heterocycle structure unit
The core skeleton of right product, causes the especially concern of synthesis chemists.Wherein, containing the loop coil oxygen for adjoining loop coil quaternary carbon center
Change Benzazole compounds and is found to have extensive pharmaceutical activity, such as antitumor activity and antibacterial activity.Especially, containing adjoining
Double loop coil Oxoindole molecules of adjacent loop coil quaternary carbon center often show special life due to its unique three-D space structure
Reason activity.
In view of containing the good bioactivity of double loop coil Oxoindole molecules for adjoining loop coil quaternary carbon center and in pharmaceutical chemistry
In application prospect, developed many methods for effectively building such compound at present.However, the prior art focuses primarily upon this
The synthesis of class compound raceme contains asymmetric syntheses the double loop coil oxidized indoles of chirality for adjoining loop coil quaternary carbon center
The report for closing object is also very limited, is primarily due to structure at least containing there are two the double spiral shells for adjoining chiral centre and space is very crowded
Epoxidation indole structure unit has prodigious difficulty.In addition, the technology of the existing such compound of asymmetric syntheses is mainly concentrated
In organic catalysis [3+2]It is cyclized cascade reaction, and it is mainly 3,3&apos to synthesize the such molecule obtained;Nafoxidine/dihydro
The bis- loop coil Oxoindoles of furans-, for chirality 3,3'The asymmetric syntheses of the bis- loop coil oxidized indole compounds of cyclopentene-, because
Lack effective Technology design, is still the work of a challenge.
Therefore, by rational asymmetric syntheses Technology design, the double spiral shells of chirality from simple raw material to structure novel are realized
Epoxidation Benzazole compounds (such as chirality 3,3'The bis- loop coil Oxoindoles of cyclopentene -) conversion, for effectively abundant chiral spiral shell
The type of epoxidation benzazolyl compounds is of great significance with the pharmaceutical chemistry research for carrying out related field.
Invention content
The invention is intended to provide, one kind is with optical activation to adjoin double loop coil oxidized indole compounds and its application, master
Foundation is provided to carry out the pharmaceutical chemistry research of related field.
One kind of the present invention is with optical activation to adjoin double loop coil oxidized indole compounds, has the following structure:
In formula:X is NR5, O or S substituent groups.
One kind of the present invention is with optical activation to adjoin double loop coil oxidized indole compounds, generally white or yellowish
Color solid is soluble in the organic solvents such as ethyl alcohol, ethyl acetate, dichloromethane, acetone, dimethyl sulfoxide (DMSO), is insoluble in water, has heat
The characteristics of mechanical stability.
Further, work as X=NR5When, R5Be each independently selected from H, Me, Et,nPr,nBu,iPr, allyl, Ph or Bn;
Correspondingly, R1It is each independently selected from H, 4-F, 4-Cl, 5-Me, 5-OMe, 5-F, 5-OCF3,5-Cl,5-Br,6-
Cl,6-Br,7-F,7-Cl,7-CF3Or 7-OCF3;
Correspondingly, R2Be each independently selected from H, Me, Et,nPr,nBu,iPr, allyl, Ph or Bn;
Correspondingly, R3Be each independently selected from Me, Et,nPr,iPr,nBu,iBu,tBu or Ph.
Correspondingly, R4It is each independently selected from H, 4-F, 4-Cl, 5-Me, 5-OMe, 5-F, 5-OCF3,5-Cl,5-Br,6-
Cl,6-Br,7-F,7-Cl,7-CF3Or 7-OCF3;
Correspondingly, R is each independently selected from Me, OMe, OEt, OiPr,OtBu, OPh, OBn, phenyl, methyl substituted-phenyl,
Methoxy substitution phenyl, fluorine substituted-phenyl, chlorine substituted-phenyl, bromine substituted-phenyl, 1- naphthalenes, 2- naphthalenes, 2- furyls or 2- thiophenes
Pheno base.
Further, as X=O or S,
Correspondingly, R1It is each independently selected from H, 4-F, 4-Cl, 5-Me, 5-OMe, 5-F, 5-OCF3,5-Cl,5-Br,6-
Cl,6-Br,7-F,7-Cl,7-CF3Or 7-OCF3;
Correspondingly, R2Be each independently selected from H, Me, Et,nPr,nBu,iPr, allyl, Ph or Bn;
Correspondingly, R3Be each independently selected from Me, Et,nPr,iPr,nBu,iBu,tBu or Ph;
Correspondingly, R4It is each independently selected from H, 5-Me, 4,6-Me2,4,7-Me2,5-OMe,4,6-(OMe)2Or 4,7-
(OMe)2;
Correspondingly, R is each independently selected from Me, OMe, OEt, OiPr,OtBu, OPh, OBn, phenyl, methyl substituted-phenyl,
Methoxy substitution phenyl, fluorine substituted-phenyl, chlorine substituted-phenyl, bromine substituted-phenyl, 1- naphthalenes, 2- naphthalenes, 2- furyls or 2- thiophenes
Pheno base.
The present invention provides a kind of preparation method with optical activation for adjoining double loop coil oxidized indole compounds, packets
It includes:
Step 1: MBH- carbonic esters, 3- carbonyl alkenyl benzo-heterocycle compounds derived from isatin are added in organic solvent
And chiral lewis base, stir 5 under 0 DEG C~50 DEG C of reaction temperature~for 24 hours;
With optical activation adjoin double loop coil oxidized indole compounds Step 2: isolated.
MBH- structural carbonates derived from isatin are shown below:
In formula:R1It is each independently selected from H, 4-F, 4-Cl, 5-Me, 5-OMe, 5-F, 5-OCF3,5-Cl,5-Br,6-Cl,
6-Br,7-F,7-Cl,7-CF3Or 7-OCF3;
R2Be each independently selected from H, Me, Et,nPr,nBu,iPr, allyl, Ph or Bn;
R3Be each independently selected from Me, Et,nPr,iPr,nBu,iBu,tBu or Ph;
3- carbonyl alkenyl benzo-heterocycle compound structures are shown below:
In formula:Work as X=NR5When, R5Be each independently selected from H, Me, Et,nPr,nBu,iPr, allyl, Ph or Bn;
Correspondingly, R4It is each independently selected from H, 4-F, 4-Cl, 5-Me, 5-OMe, 5-F, 5-OCF3,5-Cl,5-Br,6-
Cl,6-Br,7-F,7-Cl,7-CF3Or 7-OCF3;
Correspondingly, R is each independently selected from Me, OMe, OEt, OiPr,OtBu, OPh, OBn, phenyl, methyl substituted-phenyl,
Methoxy substitution phenyl, fluorine substituted-phenyl, chlorine substituted-phenyl, bromine substituted-phenyl, 1- naphthalenes, 2- naphthalenes, 2- furyls or 2- thiophenes
Pheno base;
As X=O or S,
Correspondingly, R4It is each independently selected from H, 5-Me, 4,6-Me2,4,7-Me2,5-OMe,4,6-(OMe)2Or 4,7-
(OMe)2;Correspondingly, R is each independently selected from Me, OMe, OEt, OiPr,OtBu, OPh, OBn, phenyl, methyl substituted-phenyl, first
Oxygroup substituted-phenyl, fluorine substituted-phenyl, chlorine substituted-phenyl, bromine substituted-phenyl, 1- naphthalenes, 2- naphthalenes, 2- furyls or 2- thiophene
Base.
Reaction is shown below:
Such as:By MBH- carbonic esters derived from 0.2mmol 3- carbonyl alkenyls benzo-heterocycle compound, 0.3mmol isatin and
0.04mmol(12.4mg)β-6'Hydroxyl cinchonicine is dissolved in 2mL dichloromethane, under 25 DEG C of reaction temperature, stirring 5
Hour;Then, reaction solution is directly detached with column chromatography, is obtained the corresponding pair loop coils with optical activation that adjoin and is aoxidized
Benzazole compounds.
Further, the described optics Chun Du with optical activation for adjoining double loop coil oxidized indole compounds≤
85%.
Further, the described optics Chun Du with optical activation for adjoining double loop coil oxidized indole compounds≤
95%.
Further, the described optics Chun Du with optical activation for adjoining double loop coil oxidized indole compounds≤
98%.
The optical purity of above compound is measured by high performance liquid chromatograph, and the optical purity of a chipal compounds is
The percentage of its specific rotatory power with sterling, raw material is different, and what is obtained with optical activation adjoins double loop coil oxidized indoles
Compound light purity is also different, and the optical purity of generation is higher, and the pharmaceutical activity of the compound is higher, and preferably optics Chun Du≤
When 98%, which is specifically shown in embodiment
Partial characterization value, what ee was represented is optical purity.
It is with optical activation to adjoin double loop coil oxidized indole compounds with antitumor activity, such as to human liver
Cancer, lung cancer and breast cancer cell etc. have certain inhibiting effect, as shown in the table:
Referring to upper table, choose it is wherein several it is with optical activation adjoin double loop coil oxidized indole compounds, to people source
IC50 values (i.e. the ratio between apoptosis cancer cell and whole cancer cell numbers etc. of lung cancer cell types and people source hepatoma H22 cells
The concentration of corresponding compound when 50%) it is detected, numerical value is as above, wherein 5 compound of serial number is to people source lung cancer
The IC50 values of cell line A549 are minimum, show that it is relatively strong to the inhibitory activity of lung carcinoma cell;The compound of serial number 6 is to people source
The IC50 values of hepatoma H22 cells are minimum, show that it is relatively strong to the inhibitory activity of liver cancer cells.
Specific implementation mode
It is further described below by specific implementation mode:
The specific product of the compound of the present invention, the difference of reaction raw materials, generation is as follows:
Embodiment 1:
2- (1- methyl -3- tertiary butyloxycarbonyl oxygroups -2- the oxidations of 0.3mmol (104.1mg) are added in 2mL dichloromethane
Indoline -3- bases) methyl acrylate, 1- methyl -3- (2- oxo -2- phenyl-ethylenes) indoline-of 0.2mmol (52.7mg)
2- ketone and 12.4mg β -6'Hydroxyl cinchonicine, mixture stir 5 hours under 25 DEG C of reaction temperature, and reaction process is used
Thin-layered chromatography monitors.After reaction carries out completely, mixture obtains (C1R, C4R, C5S) -3,3&apos through column chromatographic isolation and purification;-
(1- benzoyls) cyclopentenyl adjoins double loop coil Oxoindole (yield 89%, dr values 97:3, ee value >99%).
(C1R,C4R,C5S)-3,3'(1- benzoyls) cyclopentenyl adjoins the characterize data of double loop coil Oxoindoles:
[α]D 25=-101.0 (c 1.00, CHCl3);mp 230.1-231.2℃.The ee was determined by HPLC
(Chiralpak AD-H, i-PrOH/hexane=30/70, flow rate 1.0mL/min, λ=254nm, major
diastereomer:tmajor=10.5min)1H NMR(400MHz,CDCl3):δ2.98(3H,s),3.05-3.06(3H,m),
3.62-3.63 (3H, m), 4.98 (1H, d, J=2.0Hz), 6.55 (2H, dd, J=7.7Hz, 2.5Hz), 6.79 (1H, t, J=
7.6Hz), 6.94 (1H, t, J=7.6Hz), 7.09 (1H, td, J=7.7Hz, 1.3Hz), 7.15-7.18 (2H, m), 7.23-
7.24 (1H, m), 7.43-7.50 (3H, m), 7.53-7.57 (1H, m), 7.97 (2H, d, J=8.3Hz);13C NMR(100MHz,
CDCl3):δ25.9,26.4,52.5,56.0,62.3,66.6,107.9,108.0,122.4,122.5,124.1,124.6,
125.1,125.2,128.7,129.3,129.4,129.9,133.2,137.2,143.0,144.4,144.7,145.0,
169.9,175.0,176.3,191.4.HRMS(ESI-TOF)calcd.for C30H25N2O5[M+H]+493.1758;found:
493.1758。
Embodiment 2:
2- (1,5- dimethyl -3- tertiary butyloxycarbonyl oxygroups-the 2- of 0.3mmol (108.4mg) are added in 2mL dichloromethane
Oxoindole quinoline -3- bases) methyl acrylate, 1- methyl -3- (2- oxo -2- phenyl-ethylenes) Yin of 0.2mmol (52.7mg)
Diindyl quinoline -2- ketone and 12.4mg β -6'Hydroxyl cinchonicine, mixture stir 5 hours under 25 DEG C of reaction temperature, react into
Journey is monitored with thin-layered chromatography.After reaction carries out completely, mixture obtains (C1R, C4R, C5S)-through column chromatographic isolation and purification
3,3'(1- benzoyls) cyclopentenyl -5- methyl adjoins double loop coil Oxoindole (yield 70%, dr values >99:1, ee value
99%).
(C1R,C4R,C5S)-3,3'(1- benzoyls) cyclopentenyl -5- methyl adjoins the table of double loop coil Oxoindoles
Levy data:[α]D 25=-40.7 (c 0.50, CHCl3);mp 218.7-220.3℃.The ee was determined by
HPLC (Chiralpak AD-H, i-PrOH/hexane=30/70, flow rate 1.0mL/min, λ=254nm, major
diastereomer:tmajor=7.8min, tminor=11.2min)1H NMR(400MHz,CDCl3):δ2.28(3H,s),
2.97 (3H, s), 3.08 (3H, s), 3.64 (3H, s), 4.97 (1H, s), 6.45 (1H, d, J=7.9Hz), 6.56 (1H, d, J=
7.8Hz), 6.80 (1H, t, J=7.6Hz), 6.96 (1H, d, J=7.8Hz), 7.10 (1H, t, J=7.7Hz), 7.16 (1H, d,
), J=1.2Hz 7.25 (1H, s), 7.32 (1H, s), 7.47 (2H, t, J=7.5Hz), 7.56 (1H, t, J=7.3Hz), 7.99
(2H, d, J=7.6Hz);13C NMR(100MHz,CDCl3):δ21.2,25.9,26.4,52.6,55.9,62.3,66.5,
107.6,108.0,122.5,124.6,124.8,125.1,125.2,128.7,129.2,129.6,129.9,131.9,
133.2,137.2,142.0,142.9,144.6,145.1,170.0,174.9,176.2,191.4.HRMS(ESI-TOF)
calcd.for C31H27N2O5[M+H]+507.1914;found:507.1918.
Embodiment 3:
The 2-[ of 0.3mmol (113.2mg) is added in 2mL dichloromethane;1- methyl -3- tertiary butyloxycarbonyl oxygroup -2- (5- first
Oxygroup Oxoindole quinoline) -3- Jis ]Methyl acrylate, the 1- methyl -3- (2- oxo -2- phenyl Asia second of 0.2mmol (52.7mg)
Base) indole-2-ketone and 12.4mg β -6'Hydroxyl cinchonicine, mixture stir 5 hours under 25 DEG C of reaction temperature,
Reaction process is monitored with thin-layered chromatography.After reaction carries out completely, mixture obtain through column chromatographic isolation and purification (C1R, C4R,
C5S)-3,3'(1- benzoyls) cyclopentenyl -5- methoxyl groups adjoin double loop coil Oxoindole (yield 85%, dr values 97:3,
Ee values 99%).
(C1R,C4R,C5S)-3,3'(1- benzoyls) cyclopentenyl -5- methoxyl groups adjoin double loop coil Oxoindoles
Characterize data:[α]D 25=-75.3 (c 1.00, CHCl3);mp 123.7-125.5℃.The ee was determined by
HPLC (Chiralpak AD-H, i-PrOH/hexane=30/70, flow rate 1.0mL/min, λ=254nm, major
diastereomer:tmajor=14.3min, tminor=19.8min)1H NMR(400MHz,CDCl3):δ2.96(3H,s),
3.08 (3H, s), 3.62 (3H, s), 3.72 (3H, s), 4.96 (1H, d, J=1.7Hz), 6.45 (1H, d, J=8.5Hz), 6.56
(1H, d, J=7.8Hz), 6.69 (1H, dd, J=8.4Hz, 2.3Hz), 6.78 (1H, t, J=7.6Hz), 7.09 (1H, t, J=
7.6Hz), 7.14 (2H, dd, J=5.5Hz, 2.1Hz), 7.24 (1H, d, J=2.1Hz), 7.44 (2H, t, J=7.5Hz),
7.54 (1H, t, J=7.3Hz), 7.97 (2H, d, J=7.4Hz);13C NMR(100MHz,CDCl3):δ26.0,26.4,52,5,
55.9,56.1,62.5,66.5,108.0,108.3,114.3,122.5,124.6,125.1,126.4,128.6,129.3,
129.8,133.2,137.2,137.8,143.0,144.7,144.9,155.8,169.9,174.9,175.9,191.3.HRMS
(ESI-TOF)calcd.for C31H27N2O6[M+H]+523.1864;found:523.1866.
Embodiment 4:
The 2-[ of 0.3mmol (109.6mg) is added in 2mL dichloromethane;1- methyl -3- tertiary butyloxycarbonyl oxygroup -2- (5- fluorine
Oxoindole quinoline) -3- Jis ]Methyl acrylate, 1- methyl -3- (2- oxo -2- phenyl-ethylenes) Yin of 0.2mmol (52.7mg)
Diindyl quinoline -2- ketone and 12.4mg β -6'Hydroxyl cinchonicine, mixture stir 5 hours under 25 DEG C of reaction temperature, react into
Journey is monitored with thin-layered chromatography.After reaction carries out completely, mixture obtains (C1R, C4R, C5S)-through column chromatographic isolation and purification
3,3'(1- benzoyls) cyclopentenyl -5- fluorine adjoins double loop coil Oxoindole (yield 84%, dr values 96:4, ee value >
99%).
(C1R,C4R,C5S)-3,3'(1- benzoyls) cyclopentenyl -5- fluorine adjoins the characterization of double loop coil Oxoindoles
Data:[α]D 25=-144.6 (c 1.00, CHCl3);mp 197.2-199.1℃.The ee was determined by
HPLC (Chiralpak AD-H, i-PrOH/hexane=30/70, flow rate 1.0mL/min, λ=254nm, major
diastereomer:tmajor=13.3min)1H NMR(400MHz,CDCl3):δ2.99(3H,s),3.12(3H,s),3.65
(3H, s), 4.95-4.97 (1H, m), 6.50 (1H, dd, J=8.5Hz, 4.2Hz), 6.60 (1H, d, J=7.8Hz), 6.81
(1H, t, J=7.6Hz), 6.88 (1H, td, J=8.8Hz, 2.3Hz), 7.10-7.19 (2H, m), 7.25 (1H, d, J=
5.5Hz), 7.30 (1H, dd, J=8.5Hz, 2.2Hz), 7.47 (2H, t, J=7.6Hz), 7.57 (1H, t, J=7.3Hz),
7.97 (2H, d, J=7.5Hz);13C NMR(100MHz,CDCl3):δ26.1,26.5,52.6,56.2,62.3,66.5,
108.1,108.4 (1C, d, J=8.1Hz), 112.5 (1C, d, J=25.9Hz), 115.6 (1C, d, J=23.4Hz), 122.7,
124.6,124.9,127.0 (1C, d, J=8.4Hz), 128.7,129.5,129.9,133.3,137.1,140.4,143.0,
(144.6,144.7,159.1 1C, d, J=239.0Hz), 169.8,174.7,176.0,191.2.HRMS (ESI-TOF)
calcd.for C30H24FN2O5[M+H]+511.1664;found:511.1665.
Embodiment 5:
The 2-[ of 0.3mmol (127.9mg) is added in 2mL dichloromethane;1- methyl -3- tertiary butyloxycarbonyl oxygroup -2- (6- bromines
Oxoindole quinoline) -3- Jis ]Methyl acrylate, 1- methyl -3- (2- oxo -2- phenyl-ethylenes) Yin of 0.2mmol (52.7mg)
Diindyl quinoline -2- ketone and 12.4mg β -6'Hydroxyl cinchonicine, mixture stir 5 hours under 25 DEG C of reaction temperature, react into
Journey is monitored with thin-layered chromatography.After reaction carries out completely, mixture obtains (C1R, C4R, C5S)-through column chromatographic isolation and purification
3,3'(1- benzoyls) cyclopentenyl -6- bromines adjoin double loop coil Oxoindole (yield 77%, dr values 97:3, ee values 98%).
(C1R,C4R,C5S)-3,3'(1- benzoyls) cyclopentenyl -6- bromines adjoin the characterization of double loop coil Oxoindoles
Data:[α]D 25=-31.2 (c 0.50, CHCl3);mp 123.3-125.1℃.The ee was determined by
HPLC (Chiralpak AD-H, i-PrOH/hexane=30/70, flow rate 1.0mL/min, λ=254nm, major
diastereomer:tmajor=13.5min, tminor=15.3min)1H NMR(400MHz,CDCl3):δ3.03(3H,s),
3.15 (3H, s), 3.70 (3H, s), 5.01 (1H, d, J=1.4Hz), 6.67 (1H, d, J=7.8Hz), 6.78 (1H, s), 6.86
(1H, t, J=7.6Hz), 7.13 (1H, d, J=8.0Hz), 7.18-7.20 (2H, m), 7.29 (1H, d, J=4.8Hz), 7.41
(1H, d, J=8.1Hz), 7.51 (2H, t, J=7.6Hz), 7.61 (1H, t, J=7.2Hz), 8.01 (2H, d, J=7.6Hz);13C NMR(100MHz,CDCl3):δ26.1,26.5,52.7,56.1,61.8,66.3,108.3,111.6,122.7,123.2,
124.3,124.5,124.9,125.3,125.5,128.7,129.5,129.8,133.3,137.1,143.0,144.6,
144.7,145.8,169.8,174.8,176.2,191.2.HRMS(ESI-TOF)calcd.for C30H24BrN2O5[M+H]+
571.0863;found:571.0865.
Embodiment 6:
The 2-[ of 0.3mmol (109.6mg) is added in 2mL dichloromethane;1- methyl -3- tertiary butyloxycarbonyl oxygroup -2- (7- fluorine
Oxoindole quinoline) -3- Jis ]Methyl acrylate, 1- methyl -3- (2- oxo -2- phenyl-ethylenes) Yin of 0.2mmol (52.7mg)
Diindyl quinoline -2- ketone and 12.4mg β -6'Hydroxyl cinchonicine, mixture stir 5 hours under 25 DEG C of reaction temperature, react into
Journey is monitored with thin-layered chromatography.After reaction carries out completely, mixture obtains (C1R, C4R, C5S)-through column chromatographic isolation and purification
3,3'(1- benzoyls) cyclopentenyl -7- fluorine adjoins double loop coil Oxoindole (yield 78%, dr values 98:2, ee values 99%).
(C1R,C4R,C5S)-3,3'(1- benzoyls) cyclopentenyl -7- fluorine adjoins the characterization of double loop coil Oxoindoles
Data:[α]D 25=-95.1 (c 1.00, CHCl3);mp 225.3-227.1℃.The ee was determined by
HPLC (Chiralpak AD-H, i-PrOH/hexane=30/70, flow rate 1.0mL/min, λ=254nm, major
diastereomer:tmajor=8.5min, tminor=20.8min)1H NMR(400MHz,CDCl3):δ3.07(3H,s),
3.21 (3H, d, J=2.2Hz), 3.66 (3H, s), 4.97 (1H, d, J=1.5Hz), 6.60 (1H, d, J=7.8Hz), 6.83
(1H, t, J=7.6Hz), 6.87-6.93 (2H, m), 7.13-7.16 (2H, m), 7.24 (1H, d, J=6.8Hz), 7.30 (1H,
D, J=7.8Hz), 7.46 (2H, t, J=7.5Hz), 7.56 (1H, t, J=7.4Hz), 7.97 (2H, d, J=7.6Hz);13C
NMR(100MHz,CDCl3):δ 26.4,28.4,52.6,56.3,62.3,66.6,108.2,117.4 (1C, d, J=19.0Hz),
120.1 (1C, d, J=3.2Hz), 122.7,122.9 (1C, d, J=6.4Hz), 124.6,124.9,128.2 (1C, d, J=
3.3Hz), 128.7,129.6,129.8,131.1 (1C, d, J=8.3Hz), 133.3,137.1,142.9,144.5,144.7,
147.3 (1C, d, J=241.7Hz), 169.8,174.8,176.0,191.2.HRMS (ESI-TOF) calcd.for
C30H24FN2O5[M+H]+511.1664;found:511.1672.
Embodiment 7:
The 2-[ of 0.3mmol (124.6mg) is added in 2mL dichloromethane;1- methyl -3- tertiary butyloxycarbonyl oxygroup -2- (7- tri-
Methyl fluoride Oxoindole quinoline) -3- Jis ]Methyl acrylate, (2- oxo -2- phenyl is sub- by the 1- methyl -3- of 0.2mmol (52.7mg)
Ethyl) indole-2-ketone and 12.4mg β -6'Hydroxyl cinchonicine, it is small that mixture stirs 5 under 25 DEG C of reaction temperature
When, reaction process is monitored with thin-layered chromatography.After reaction carries out completely, mixture obtain through column chromatographic isolation and purification (C1R,
C4R,C5S)-3,3'(1- benzoyls) cyclopentenyl -7- trifluoromethyls adjoin double loop coil Oxoindole (yield 89%, dr values
>99:1, ee value 87%).
(C1R,C4R,C5S)-3,3'(1- benzoyls) cyclopentenyl -7- trifluoromethyls adjoin double loop coil Oxoindoles
Characterize data:[α]D 25=-110.0 (c 1.00, CHCl3);mp 125.8.-127.1℃.The ee was
Determined by HPLC (Chiralpak AD-H, i-PrOH/hexane=30/70, flow rate 1.0mL/min, λ
=254nm, major diastereomer:tmajor=6.6min, tminor=13.3min)1H NMR(400MHz,CDCl3):δ
3.06 (3H, s), 3.21 (3H, s), 3.67 (3H, s), 5.00 (1H, s), 6.60 (1H, d, J=7.8Hz), 6.84 (1H, t, J=
7.6Hz), 7.05 (1H, t, J=7.9Hz), 7.13-7.20 (3H, m), 7.49 (3H, t, J=7.4Hz), 7.59 (1H, t, J=
7.4Hz), 7.72 (1H, d, J=7.6Hz), 7.99 (2H, d J=7.8Hz);13C NMR(100MHz,CDCl3):δ26.4,
28.6 (1C, q, J=6.5Hz), 52.7,56.0,60.7,108.3,112.2 (1C, q, J=3.3Hz), 121.6,122.8,
124.3,124.5,124.7,127.3 (1C, q, J=6.0Hz), 127.4,127.8,128.7,129.6,129.8,133.4,
137.0,142.4,142.6,144.4,144.6,169.7,174.6,177.2,191.1.HRMS(ESI-TOF)calcd.for
C31H24F3N2O5[M+H]+561.1632;found:561.1639.
Embodiment 8:
2- (1- propyl -3- tertiary butyloxycarbonyl oxygroups -2- the oxidations of 0.3mmol (112.6mg) are added in 2mL dichloromethane
Indoline) -3- Jis ]Methyl acrylate, 1- methyl -3- (2- oxo -2- phenyl-ethylenes) indoles of 0.2mmol (52.7mg)
Quinoline -2- ketone and 12.4mg β -6'Hydroxyl cinchonicine, mixture stir 5 hours under 25 DEG C of reaction temperature, reaction process
It is monitored with thin-layered chromatography.After reaction carries out completely, mixture obtains (C1R, C4R, C5S) -3 through column chromatographic isolation and purification,
3'(1- benzoyls) cyclopentenyl -1- propyl adjoins double loop coil Oxoindole (yield 53%, dr values 97:3, ee values 89%).
(C1R,C4R,C5S)-3,3'(1- benzoyls) cyclopentenyl -1- propyl adjoins the table of double loop coil Oxoindoles
Levy data:[α]D 25=-147.3 (c 1.00, CHCl3);mp 105.5-107.3℃.The ee was determined by
HPLC (Chiralpak AD-H, i-PrOH/hexane=30/70, flow rate 1.0mL/min, λ=254nm, major
diastereomer:tmajor=7.3min, tminor=14.0min)1H NMR(400MHz,CDCl3):δ 0.84 (3H, t, J=
7.3Hz), 1.53 (2H, q, J=7.4Hz), 3.08 (3H, s), 3.46 (2H, t, J=7.5Hz), 3.63 (3H, s), 4.99 (1H,
D, J=1.8Hz), 6.59 (2H, t, J=8.9Hz), 6.80 (1H, t, J=7.6Hz), 6.95 (1H, t, J=7.6Hz), 7.11
(1H, t, J=7.8Hz), 7.16-7.19 (2H, m), 7.29 (1H, d, J=7.6Hz), 7.47 (2H, t, J=7.7Hz), 7.52-
7.60 (2H, m), 8.00 (2H, d, J=8.2Hz);13C NMR(100MHz,CDCl3):δ11.6,20.7,26.4,41.8,
52.5,56.2,62.0,66.6,108.0,108.2,122.2,122.6,124.3,124.9,125.2,125.4,128.7,
129.2,129.3,129.9,133.2,137.2,143.0,144.2,144.7,145.0,169.8,175.1,176.1,
191.4.HRMS(ESI-TOF)calcd.for C32H29N2O5[M+H]+521.2071;found:521.2080.
Embodiment 9:
2- (1- phenyl -3- tertiary butyloxycarbonyl oxygroups -2- the oxidations of 0.3mmol (122.8mg) are added in 2mL dichloromethane
Indoline) -3- Jis ]Methyl acrylate, 1- methyl -3- (2- oxo -2- phenyl-ethylenes) indoles of 0.2mmol (52.7mg)
Quinoline -2- ketone and 12.4mg β -6'Hydroxyl cinchonicine, mixture stir 5 hours under 25 DEG C of reaction temperature, reaction process
It is monitored with thin-layered chromatography.After reaction carries out completely, mixture obtains (C1R, C4R, C5S) -3 through column chromatographic isolation and purification,
3'(1- benzoyls) cyclopentenyl -1- phenyl adjoins double loop coil Oxoindole (yield 85%, dr values >99:1, ee value
98%).
(C1R,C4R,C5S)-3,3'(1- benzoyls) cyclopentenyl -1- phenyl adjoins the table of double loop coil Oxoindoles
Levy data:[α]D 25=-153.0 (c 1.00, CHCl3);mp 128.7-129.6℃.The ee was determined by
HPLC (Chiralpak AD-H, i-PrOH/hexane=30/70, flow rate 1.0mL/min, λ=254nm, major
diastereomer:tmajor=6.8min, tminor=11.5min)1H NMR(400MHz,CDCl3):δ3.13(3H,s),
3.72 (3H, s), 5.10 (1H, d, J=2.0Hz), 6.44 (1H, d, J=7.8Hz), 6.65 (1H, d, J=7.8Hz), 6.84
(1H, t, J=7.6Hz), 7.00 (1H, t, J=7.6Hz), 7.09-7.12 (3H, m), 7.17-7.21 (2H, m), 7.30 (1H,
D, J=7.5Hz), 7.37-7.49 (5H, m), 7.54-7.60 (2H, m), 7.99 (2H, d, J=8.3Hz);13C NMR
(100MHz,CDCl3):δ26.4,52.6,56.5,62.2,66.7,108.1,109.2,122.7,122.8,124.3,124.9,
125.1,125.2,127.1,128.5,128.6,129.2,129.4,129.7,129.9,133.2,134.2,137.2,
142.9,144.7,144.8,169.9,174.9,175.9,191.4.HRMS(ESI-TOF)calcd.for C35H27N2O5[M+
H]+555.1914;found:555.1911.
Embodiment 10:
2- (1- benzyl -3- tertiary butyloxycarbonyl oxygroups -2- the oxidations of 0.3mmol (127.0mg) are added in 2mL dichloromethane
Indoline) -3- Jis ]Methyl acrylate, 1- methyl -3- (2- oxo -2- phenyl-ethylenes) indoles of 0.2mmol (52.7mg)
Quinoline -2- ketone and 12.4mg β -6'Hydroxyl cinchonicine, mixture stir 5 hours under 25 DEG C of reaction temperature, reaction process
It is monitored with thin-layered chromatography.After reaction carries out completely, mixture obtains (C1R, C4R, C5S) -3 through column chromatographic isolation and purification,
3'(1- benzoyls) cyclopentenyl -1- benzyls adjoin double loop coil Oxoindole (yield 62%, dr values 98:2, ee value >
99%).
(C1R,C4R,C5S)-3,3'(1- benzoyls) cyclopentenyl -1- benzyls adjoin the table of double loop coil Oxoindoles
Levy data:[α]D 25=-71.2 (c 1.00, CHCl3);mp 193.7-195.6℃.The ee was determined by
HPLC (Chiralpak AD-H, i-PrOH/hexane=30/70, flow rate 1.0mL/min, λ=254nm, major
diastereomer:tmajor=15.7min)1H NMR(400MHz,CDCl3):δ3.11(3H,s),3.62(3H,s),4.70
(1H, d, J=16.0Hz), 4.83 (1H, d, J=16.0Hz), 5.04 (1H, s), 6.42 (1H, d, J=7.7Hz), 6.64 (1H,
D, J=7.7Hz), 6.76 (1H, t, J=7.5Hz), 6.94-6.98 (3H, m), 7.08 (1H, t, J=7.6Hz), 7.15-7.20
(5H, m), 7.30 (1H, d, J=7.4Hz), 7.49 (2H, t, J=7.3Hz), 7.56-7.60 (2H, m), 8.01 (2H, d, J=
7.6Hz);13C NMR(100MHz,CDCl3):δ26.5,43.8,52.6,56.6,62.2,66.7,108.2,109.2,110.1,
122.5,123.0,124.4,125.1,125.3,125.4,127.2,127.4,128.7,129.2,129.3,129.9,
133.2,135.3,137.2,143.0,143.9,144.8,144.9,169.8,175.1,176.4,191.3.HRMS(ESI-
TOF)calcd.for C36H29N2O5[M+H]+569.2071;found:569.2075.
Embodiment 11:
2- (1- methyl -3- tertiary butyloxycarbonyl oxygroups -2- the oxidations of 0.3mmol (104.1mg) are added in 2mL dichloromethane
Indoline -3- bases) methyl acrylate, 1- ethyls -3- (2- oxo -2- phenyl-ethylenes) indoline-of 0.2mmol (55.5mg)
2- ketone and 12.4mg β -6'Hydroxyl cinchonicine, mixture stir 5 hours under 25 DEG C of reaction temperature, and reaction process is used
Thin-layered chromatography monitors.After reaction carries out completely, mixture obtains (C1R, C4R, C5S) -3,3&apos through column chromatographic isolation and purification;-
(1- benzoyls) cyclopentenyl -1'Ethyl adjoins double loop coil Oxoindole (yield 90%, dr values 86:14, ee values 99%).
(C1R,C4R,C5S)-3,3'(1- benzoyls) cyclopentenyl -1'Ethyl adjoins the table of double loop coil Oxoindoles
Levy data:[α]D 25=-130.7 (c 1.00, CHCl3);mp 79.5-81.3℃.The ee was determined by
HPLC (Chiralpak AD-H, i-PrOH/hexane=30/70, flow rate 1.0mL/min, λ=254nm, major
diastereomer:tmajor=9.8min, tminor=22.9min)1H NMR(400MHz,CDCl3):δ 1.07 (3H, t, J=
7.2Hz),3.02(3H,s),3.49-3.57(1H,m),3.65(3H,s),3.77-3.86(1H,m),5.01(1H,s),6.58-
6.61 (2H, m), 6.80 (1H, t, J=7.6Hz), 6.97 (1H, t, J=7.6Hz), 7.11 (1H, t, J=7.7Hz), 7.16-
7.21 (2H, m), 7.29 (1H, d, J=7.6Hz), 7.47 (2H, t, J=7.5Hz), 7.54-7.59 (2H, m), 8.00 (2H, d,
J=8.0Hz);13C NMR(100MHz,CDCl3):δ12.49,25.93,34.94,52.54,56.12,62.21,66.29,
76.84,77.16,77.48,107.97,108.14,122.34,122.50,124.53,124.84,125.25,125.46,
128.65,129.26,129.90,133.19,137.28,143.20,143.93,144.44,144.71,169.96,174.62,
176.39,191.37.HRMS(ESI-TOF)calcd.for C31H27N2O5[M+H]+507.1914;found:507.1919.
Embodiment 12:
2- (1- methyl -3- tertiary butyloxycarbonyl oxygroups -2- the oxidations of 0.3mmol (104.1mg) are added in 2mL dichloromethane
Indoline -3- bases) methyl acrylate, 1- propyl -3- (2- oxo -2- phenyl-ethylenes) indoline-of 0.2mmol (58.3mg)
2- ketone and 12.4mg β -6'Hydroxyl cinchonicine, mixture stir 5 hours under 25 DEG C of reaction temperature, and reaction process is used
Thin-layered chromatography monitors.After reaction carries out completely, mixture obtains (C1R, C4R, C5S) -3,3&apos through column chromatographic isolation and purification;-
(1- benzoyls) cyclopentenyl -1'Propyl adjoins double loop coil Oxoindole (yield 76%, dr values 97:3, ee value >99%).
(C1R,C4R,C5S)-3,3'(1- benzoyls) cyclopentenyl -1'Propyl adjoins the table of double loop coil Oxoindoles
Levy data:[α]D 25=-116.5 (c 1.00, CHCl3);mp 105.9-107.8℃.The ee was determined by
HPLC (Chiralpak AD-H, i-PrOH/hexane=30/70, flow rate 1.0mL/min, λ=254nm, major
diastereomer:tmajor=9.4min)1H NMR(400MHz,CDCl3):δ 0.85 (3H, t, J=7.4Hz), 1.51-
1.59 (2H, m), 3.02 (3H, s), 3.43-3.51 (1H, m), 3.61-3.70 (4H, m), 5.01 (1H, d, J=2.2Hz),
6.60 (2H, dd, J=7.8Hz, 2.7Hz), 6.80 (1H, t, J=7.6Hz), 6.96 (1H, t, J=7.6Hz), 7.10 (1H, t,
), J=7.7Hz 7.15 (1H, d, J=2.2Hz), 7.19 (1H, t, J=7.8Hz), 7.29 (1H, d, J=7.6Hz), 7.48
(2H, t, J=7.7Hz), 7.53-7.58 (2H, m), 8.00 (2H, d, J=7.2Hz);13C NMR(100MHz,CDCl3):δ
11.5,20.9,25.9,42.0,52.5,56.1,62.1,66.2,107.9,108.3,122.2,122.5,124.5,124.7,
125.2,125.3,128.6,129.2,129.3,129.9,133.1,137.2,143.2,144.4,144.5,144.6,
169.9,174.9,176.4,191.3.HRMS(ESI-TOF)calcd.for C32H29N2O5[M+H]+521.2071;found:
521.2076。
Embodiment 13:
2- (1- methyl -3- tertiary butyloxycarbonyl oxygroups -2- the oxidations of 0.3mmol (104.1mg) are added in 2mL dichloromethane
Indoline -3- bases) methyl acrylate, 1- phenyl -3- (2- oxo -2- phenyl-ethylenes) indoline-of 0.2mmol (65.1mg)
2- ketone and 12.4mg β -6'Hydroxyl cinchonicine, mixture stir 5 hours under 25 DEG C of reaction temperature, and reaction process is used
Thin-layered chromatography monitors.After reaction carries out completely, mixture obtains (C1R, C4R, C5S) -3,3&apos through column chromatographic isolation and purification;-
(1- benzoyls) cyclopentenyl -1'Phenyl adjoins double loop coil Oxoindole (yield 72%, dr values >99:1, ee value >99%).
(C1R,C4R,C5S)-3,3'(1- benzoyls) cyclopentenyl -1'Phenyl adjoins the table of double loop coil Oxoindoles
Levy data:[α]D 25=-24.1 (c 1.00, CHCl3);mp 140.3-142.1℃.The ee was determined by
HPLC (Chiralpak OD-H, i-PrOH/hexane=10/90, flow rate 1.0mL/min, λ=254nm, major
diastereomer:tmajor=23.3min)1H NMR(400MHz,CDCl3):δ3.12(3H,s),3.73(3H,s),5.07
(1H, s), 5.36 (1H, s), 6.48 (1H, d, J=7.9Hz), 6.72 (1H, d, J=7.8Hz), 6.91 (1H, t, J=
7.6Hz), 7.04-7.11 (2H, m), 7.24 (1H, s), 7.31-7.35 (2H, m), 7.41 (1H, d, J=7.6Hz), 7.45-
7.48 (1H, m), 7.53-7.61 (5H, m), 7.65-7.68 (1H, m), 8.12 (2H, d, J=7.8Hz);13C NMR(100MHz,
CDCl3):δ26.0,52.6,56.0,62.4,66.9,108.1,109.3,122.6,122.9,124.7,124.8,124.9,
125.3,127.4,128.5,128.7,129.2,129.5,129.7,129.9,133.3,134.4,137.2,143.2,
144.5,144.8,145.2,170.0,174.6,176.3,191.3.HRMS(ESI-TOF)calcd.for C35H27N2O5[M+
H]+555.1914;found:555.1915.
Embodiment 14:
2- (1- methyl -3- tertiary butyloxycarbonyl oxygroups -2- the oxidations of 0.3mmol (104.1mg) are added in 2mL dichloromethane
Indoline -3- bases) methyl acrylate, 1- benzyls -3- (2- oxo -2- phenyl-ethylenes) indoline-of 0.2mmol (67.8mg)
2- ketone and 12.4mg β -6'Hydroxyl cinchonicine, mixture stir 5 hours under 25 DEG C of reaction temperature, and reaction process is used
Thin-layered chromatography monitors.After reaction carries out completely, mixture obtains (C1R, C4R, C5S) -3,3&apos through column chromatographic isolation and purification;-
(1- benzoyls) cyclopentenyl -1'Benzyl adjoins double loop coil Oxoindole (yield 72%, dr values >99:1, ee value >99%).
(C1R,C4R,C5S)-3,3'(1- benzoyls) cyclopentenyl -1'Benzyl adjoins the table of double loop coil Oxoindoles
Levy data:[α]D 25=-117.1 (c 1.00, CHCl3);mp 101.7-103.0℃.The ee was determined by
HPLC (Chiralpak OD-H, i-PrOH/hexane=10/90, flow rate 1.0mL/min, λ=254nm, major
diastereomer:tmajor=30.7min)1H NMR(400MHz,CDCl3):δ3.04(3H,s),3.66(3H,s),4.74
(1H, d, J=16.2Hz), 5.02 (1H, d, J=16.9Hz), 5.04 (1H, s), 6.36 (1H, d, J=7.8Hz), 6.66 (1H,
D, J=7.8Hz), 6.79 (1H, t, J=7.6Hz), 6.91-7.00 (4H, m), 7.18-7.26 (5H, m), 7.33 (1H, d, J=
7.5Hz), 7.48-7.54 (3H, m), 7.59 (1H, t, J=7.3Hz), 8.02 (2H, d, J=7.6Hz);13C NMR(100MHz,
CDCl3):δ26.0,44.1,52.6,56.3,62.2,66.6,108.2,109.4,122.7,122.9,124.3,125.5,
126.9,127.3,128.6,128.7,129.3,129.3,129.9,133.3,139.3,137.3,143.4,144.2,
144.6,144.8,169.9,175.3,176.5,191.4,HRMS(ESI-TOF)calcd.for C36H29N2O5[M+H]+
569.2071;found:569.2077.
Embodiment 15:
2- (1- methyl -3- tertiary butyloxycarbonyl oxygroups -2- the oxidations of 0.3mmol (104.1mg) are added in 2mL dichloromethane
Indoline -3- bases) methyl acrylate, the 1- tertbutyloxycarbonyls -3- (2- oxo -2- phenyl-ethylenes) of 0.2mmol (69.9mg)
Indole-2-ketone and 12.4mg β -6'Hydroxyl cinchonicine, mixture stir 5 hours under 25 DEG C of reaction temperature, reaction
Process is monitored with thin-layered chromatography.After reaction carries out completely, mixture obtain through column chromatographic isolation and purification (C1R, C4R,
C5S)-3,3'(1- benzoyls) cyclopentenyl -1'Tertbutyloxycarbonyl adjoins double loop coil Oxoindole (yield 26%, dr values >
99:1, ee value 83%).
(C1R,C4R,C5S)-3,3'(1- benzoyls) cyclopentenyl -1'Tertbutyloxycarbonyl adjoins double loop coil oxidation Yin
The characterize data of diindyl:[α]D 25=-100.3 (c 1.00, CHCl3);mp 163.1-165.0℃.The ee was
Determined by HPLC (Chiralpak AD-H, i-PrOH/hexane=10/90, flow rate 1.0mL/min, λ
=254nm, major diastereomer:tmajor=22.0min, tminor=44.8min)1H NMR(400MHz,CDCl3):
δ 1.61 (9H, s), 2.97 (3H, s), 3.66 (3H, s), 4.89 (1H, s), 6.60 (1H, d, J=7.8Hz), 6.90-6.99
(2H, m), 7.15 (1H, t, J=7.9Hz), 7.20-7.24 (2H, m), 7.29 (1H, d, J=7.6Hz), 7.45-7.51 (3H,
M), 7.58-7.62 (2H, m), 7.99 (2H, d, J=8.2Hz);13C NMR(100MHz,CDCl3):δ26.0,28.2,52.7,
55.9,63.1,67.0,84.2,108.2,114.9,122.6,124.0,124.1,124.3,124.4,124.5,128.8,
129.5,129.7,129.9,133.4,136.9,140.6,142.5,144.4,145.5,148.7,169.7,173.5,
175.6,190.9.HRMS(ESI-TOF)calcd.for C34H31N2O7[M+H]+579.2126;found:579.2131.
Embodiment 16:
2- (1- methyl -3- tertiary butyloxycarbonyl oxygroups -2- the oxidations of 0.3mmol (104.1mg) are added in 2mL dichloromethane
Indoline -3- bases) methyl acrylate, 1,5- dimethyl -3- (2- oxo -2- phenyl-ethylenes) Yin of 0.2mmol (55.4mg)
Diindyl quinoline -2- ketone and 12.4mg β -6'Hydroxyl cinchonicine, mixture stir 5 hours under 25 DEG C of reaction temperature, react into
Journey is monitored with thin-layered chromatography.After reaction carries out completely, mixture obtains (C1R, C4R, C5S)-through column chromatographic isolation and purification
3,3'(1- benzoyls) cyclopentenyl -5'Methyl adjoins double loop coil Oxoindole (yield 62%, dr values 96:4, ee values
95%).
(C1R,C4R,C5S)-3,3'(1- benzoyls) cyclopentenyl -5'Methyl adjoins the table of double loop coil Oxoindoles
Levy data:[α]D 25=-98.8 (c 1.00, CHCl3);mp 167.1-168.3℃.The ee was determined by
HPLC (Chiralpak AD-H, i-PrOH/hexane=30/70, flow rate 1.0mL/min, λ=254nm, major
diastereomer:tmajor=8.6min, tminOr=18.0min)1H NMR(400MHz,CDCl3):δ2.15(3H,s),
3.01 (3H, s), 3.06 (3H, s), 3.66 (3H, s), 5.00 (1H, d, J=1.9Hz), 6.46 (1H, d, J=7.9Hz), 6.58
(1H, d, J=7.8Hz), 6.91 (1H, d, J=7.8Hz), 6.96 (1H, t, J=7.6Hz), 7.09 (1H, s), 7.17-7.20
(2H, m), 7.49 (3H, t, J=7.2Hz), 7.59 (1H, t, J=7.3Hz), 8.00 (2H, d, J=7.4Hz);13C NMR
(100MHz,CDCl3):δ21.2,25.9,26.5,52.6,55.9,62.4,66.7,107.7,107.9,122.4,124.1,
125.1,125.3,128.7,129.3,129.6,129.9,132.0,133.2,137.3,142.3,143.0,144.4,
145.2,170.0,174.9,176.3,191.4.HRMS(ESI-TOF)calcd.for C31H26N2O5[M+H]+507.1914;
found:507.1917。
Embodiment 17:
2- (1- methyl -3- tertiary butyloxycarbonyl oxygroups -2- the oxidations of 0.3mmol (104.1mg) are added in 2mL dichloromethane
Indoline -3- bases) methyl acrylate, 1- methyl -3- (2- oxo -2- phenyl-ethylenes) -5- methoxies of 0.2mmol (58.7mg)
Base indole-2-ketone and 12.4mg β -6'Hydroxyl cinchonicine, mixture stir 5 hours under 25 DEG C of reaction temperature, instead
Process is answered to be monitored with thin-layered chromatography.After reaction carries out completely, mixture obtain through column chromatographic isolation and purification (C1R, C4R,
C5S)-3,3'(1- benzoyls) cyclopentenyl -5'Methoxyl group adjoins double loop coil Oxoindole (yield 55%, dr values 96:4,
Ee values >99%).
(C1R,C4R,C5S)-3,3'(1- benzoyls) cyclopentenyl -5'Methoxyl group adjoins double loop coil Oxoindoles
Characterize data:[α]D 25=-58.6 (c 1.00, CHCl3);mp 113.7-114.9℃.The ee was determined by
HPLC (Chiralpak AD-H, i-PrOH/hexane=30/70, flow rate 1.0mL/min, λ=254nm, major
diastereomer:tmajor=12.7min)1H NMR(400MHz,CDCl3):δ3.05(3H,s),3.06(3H,s),3.62
(3H, s), 3.65 (3H, s), 5.01 (1H, s), 6.48 (1H, d, J=8.4Hz), 6.61 (1H, d, J=7.7Hz), 6.65 (1H,
Dd, J=8.4Hz, 1.9Hz), 6.95-6.99 (2H, m), 7.17-7.21 (2H, m), 7.46-7.53 (3H, m), 7.58 (1H, t,
), J=7.2Hz 8.00 (2H, d, J=7.7Hz);13C NMR(100MHz,CDCl3):δ26.0,26.5,52.5,55.8,56.2,
62.3,66.8,108.0,108.3,111.7,114.0,122.5,124.3,125.2,126.4,128.7,129.3,129.9,
133.2,137.3,138.3,143.0,144.4,145.1,155.8,169.9,174.7,176.3,191.3.HRMS(ESI-
TOF)calcd.for C31H26N2O6[M+H]+523.1864;found:523.1866.
Embodiment 18:
2- (1- methyl -3- tertiary butyloxycarbonyl oxygroups -2- the oxidations of 0.3mmol (104.1mg) are added in 2mL dichloromethane
Indoline -3- bases) methyl acrylate, 1- methyl -3- (2- oxo -2- phenyl-ethylenes) -5- fluorine Yin of 0.2mmol (56.2mg)
Diindyl quinoline -2- ketone and 12.4mg β -6'Hydroxyl cinchonicine, mixture stir 5 hours under 25 DEG C of reaction temperature, react into
Journey is monitored with thin-layered chromatography.After reaction carries out completely, mixture obtains (C1R, C4R, C5S)-through column chromatographic isolation and purification
3,3'(1- benzoyls) cyclopentenyl -5'Fluorine adjoins double loop coil Oxoindole (yield 91%, dr values 98:2, ee values
98%).
(C1R,C4R,C5S)-3,3'(1- benzoyls) cyclopentenyl -5'Fluorine adjoins the characterization of double loop coil Oxoindoles
Data:[α]D 25=-112.3 (c 1.00, CHCl3);mp 209.8-210.3℃.The ee was determined by
HPLC (Chiralpak AD-H, i-PrOH/hexane=30/70, flow rate 1.0mL/min, λ=254nm, major
diastereomer:tmajor=12.4min, tminor=20.8min)1H NMR(400MHz,CDCl3):δ3.06(3H,s),
3.08 (3H, s), 3.65 (3H, s), 5.01 (1H, d, J=1.5Hz), 6.51 (1H, dd, J=8.5Hz, 4.1Hz), 6.63 (1H,
D, J=7.8Hz), 6.83 (1H, td, J=8.8Hz, J=2.3Hz), 6.98 (1H, t, J=7.6Hz), 7.08 (1H, dd, J=
8.5Hz, J=2.2Hz), 7.19-7.23 (2H, m), 7.47-7.51 (3H, m), 7.59 (1H, t, J=7.4Hz), 7.99 (2H,
D, J=7.5Hz);13C NMR(100MHz,CDCl3):δ26.0,26.6,52.6,56.2,62.1,66.5,108.1,108.4
(1C, d, J=8.2Hz), 112.8 (1C, d, J=25.9Hz), 115.5 (1C, d, J=23.4Hz), 122.6,124.2,
124.9,126.9 (1C, d, J=8.4Hz), 128.7,129.5,129.8,133.4,137.0,140.7,142.7,144.3,
145.4,159.1 (1C, d, J=238.8Hz), 169.7,174.8,176.0,191.2.HRMS (ESI-TOF) calcd.for
C30H24FN2O5[M+H]+511.1664;found:511.1669.
Embodiment 19:
2- (1- methyl -3- tertiary butyloxycarbonyl oxygroups -2- the oxidations of 0.3mmol (104.1mg) are added in 2mL dichloromethane
Indoline -3- bases) methyl acrylate, 1- methyl -3- (2- oxo -2- phenyl-ethylenes) -5- chlorine Yin of 0.2mmol (59.5mg)
Diindyl quinoline -2- ketone and 12.4mg β -6'Hydroxyl cinchonicine, mixture stir 5 hours under 25 DEG C of reaction temperature, react into
Journey is monitored with thin-layered chromatography.After reaction carries out completely, mixture obtains (C1R, C4R, C5S)-through column chromatographic isolation and purification
3,3'(1- benzoyls) cyclopentenyl -5'Chlorine adjoins double loop coil Oxoindole (yield 73%, dr values 97:3, ee values
97%).
(C1R,C4R,C5S)-3,3'(1- benzoyls) cyclopentenyl -5'Chlorine adjoins the characterization of double loop coil Oxoindoles
Data:[α]D 25=-35.8 (c 1.00, CHCl3);mp 119.7-121.9℃.The ee was determined by
HPLC (Chiralpak AD-H, i-PrOH/hexane=10/90, flow rate 1.0mL/min, λ=254nm, major
diastereomer:tmajor=41.4min, tminor=60.0min)1H NMR(400MHz,CDCl3):δ3.06(3H,s),
3.07 (3H, s), 3.66 (3H, s), 4.99 (1H, s), 6.51 (1H, d, J=8.3Hz), 6.62 (1H, d, J=7.8Hz), 6.97
(1H, t, J=7.6Hz), 7.10 (1H, d, J=8.2Hz), 7.20-7.23 (2H, m), 7.28 (1H, s), 7.46-7.52 (3H,
M), 7.60 (1H, t, J=7.2Hz), 7.98 (2H, d, J=7.7Hz);13C NMR(100MHz,CDCl3):δ26.0,26.6,
52.7,56.0,62.2,66.5,108.2,108.9,122.6,124.1,124.9,125.0,126.9,128.0,128.8,
129.3,129.5,129.9,133.4,137.1,142.6,143.4,144.4,145.7,169.7,174.6,176.0,
191.2.HRMS(ESI-TOF)calcd.for C30H24ClN2O5[M+H]+527.1368;found:527.1375.
Embodiment 20:
2- (1- methyl -3- tertiary butyloxycarbonyl oxygroups -2- the oxidations of 0.3mmol (104.1mg) are added in 2mL dichloromethane
Indoline -3- bases) methyl acrylate, 1- methyl -3- (2- oxo -2- phenyl-ethylenes) -5- bromines Yin of 0.2mmol (68.4mg)
Diindyl quinoline -2- ketone and 12.4mg β -6'Hydroxyl cinchonicine, mixture stir 5 hours under 25 DEG C of reaction temperature, react into
Journey is monitored with thin-layered chromatography.After reaction carries out completely, mixture obtains (C1R, C4R, C5S)-through column chromatographic isolation and purification
3,3'(1- benzoyls) cyclopentenyl -5'Bromine adjoins double loop coil Oxoindole (yield 87%, dr values >99:1, ee value
98%).
(C1R,C4R,C5S)-3,3'(1- benzoyls) cyclopentenyl -5'Bromine adjoins the characterization of double loop coil Oxoindoles
Data:[α]D 25=4.5 (c 1.00, CHCl3);mp 134.6-136.5℃.The ee was determined by HPLC
(Chiralpak AD-H, i-PrOH/hexane=30/70, flow rate 1.0mL/min, λ=254nm, major
diastereomer:tmajor=12.9min, tminor=18.7min)1H NMR(400MHz,CDCl3):δ2.92(6H,s),
3.51 (3H, s), 4.83 (1H, s), 6.31 (1H, d, J=8.3Hz), 6.47 (1H, d, J=7.8Hz), 6.82 (1H, t, J=
7.6Hz), 7.04-7.11 (4H, m), 7.30-7.37 (3H, m), 7.44-7.48 (1H, m), 7.84 (2H, d, J=7.8Hz);13C
NMR(100MHz,CDCl3):δ25.9,26.5,52.6,55.8,62.1,66.4,108.1,109.4,115.2,122.5,
124.0,124.8,127.2,127.6,128.7,129.5,129.8,132.2,133.4,137.0,142.5,143.8,
144.3,145.7,169.7,174.4,176.0,191.1.HRMS(ESI-TOF)calcd.for C30H24BrN2O5[M+H]+
571.0863;found:571.0875.
Embodiment 21:
2- (1- methyl -3- tertiary butyloxycarbonyl oxygroups -2- the oxidations of 0.3mmol (104.1mg) are added in 2mL dichloromethane
Indoline -3- bases) methyl acrylate, 1- methyl -3- (2- oxo -2- phenyl-ethylenes) -7- fluorine Yin of 0.2mmol (56.2mg)
Diindyl quinoline -2- ketone and 12.4mg β -6'Hydroxyl cinchonicine, mixture stir 5 hours under 25 DEG C of reaction temperature, react into
Journey is monitored with thin-layered chromatography.After reaction carries out completely, mixture obtains (C1R, C4R, C5S)-through column chromatographic isolation and purification
3,3'(1- benzoyls) cyclopentenyl -7'Fluorine adjoins double loop coil Oxoindole (yield 45%, dr values 96:4, ee values
95%).
(C1R,C4R,C5S)-3,3'(1- benzoyls) cyclopentenyl -7'Fluorine adjoins the characterization of double loop coil Oxoindoles
Data:[α]D 25=-64.8 (c 1.00, CHCl3);mp 192.4-193.3℃.The ee was determined by
HPLC (Chiralpak AD-H, i-PrOH/hexane=30/70, flow rate 1.0mL/min, λ=254nm, major
diastereomer:tmajor=10.0min, tminor=15.1min)1H NMR(400MHz,CDCl3):δ3.01(3H,s),
3.30 (3H, s), 3.65 (3H, s), 4.99 (1H, s), 6.63 (1H, d, J=7.8Hz), 6.72-6.77 (1H, m), 6.82-
6.87 (1H, m), 7.00 (1H, t, J=7.6Hz), 7.08 (1H, d, J=7.5Hz), 7.18 (1H, s), 7.23 (1H, d, J=
7.8Hz), 7.48-7.51 (3H, m), 7.59 (1H, t, J=7.3Hz), 7.99 (2H, d, J=7.9Hz);13C NMR(100MHz,
CDCl3):δ 26.0,29.0,52.6,56.0,62.3,66.6,108.1,117.4 (1C, d, J=19.1Hz), 120.5,
122.7,123.3 (1C, d, J=6.5Hz), 124.1,124.9,128.1 (1C, d, J=3.6Hz), 128.7,129.6,
129.9,133.4,137.1,142.8,144.4,145.3,147.3 (1C, d, J=241.7Hz), 169.8,174.7,176.1,
191.3.HRMS(ESI-TOF)calcd.for C30H24FN2O5[M+H]+511.1664;found:511.1673.
Embodiment 22:
2- (1- methyl -3- tertiary butyloxycarbonyl oxygroups -2- the oxidations of 0.3mmol (104.1mg) are added in 2mL dichloromethane
Indoline -3- bases) methyl acrylate, 1- methyl -3- (2- oxo -2- phenyl-ethylenes) -7- bromines Yin of 0.2mmol (68.4mg)
Diindyl quinoline -2- ketone and 12.4mg β -6'Hydroxyl cinchonicine, mixture stir 5 hours under 25 DEG C of reaction temperature, react into
Journey is monitored with thin-layered chromatography.After reaction carries out completely, mixture obtains (C1R, C4R, C5S)-through column chromatographic isolation and purification
3,3'(1- benzoyls) cyclopentenyl -7'Bromine adjoins double loop coil Oxoindole (yield 43%, dr values 98:2, ee values
95%).
(C1R,C4R,C5S)-3,3'(1- benzoyls) Huan Wuxiji ]-7'Bromine adjoins the table of double loop coil Oxoindoles
Levy data:[α]D 25=-108.1 (c 1.00, CHCl3);mp 248.3-250.1℃.The ee was determined by
HPLC (Chiralpak AD-H, i-PrOH/hexane=30/70, flow rate 1.0mL/min, λ=254nm, major
diastereomer:tmajor=10.2min, tminor=18.6min)1H NMR(400MHz,CDCl3):δ2.99(3H,s),
3.45 (3H, s), 3.63 (3H, s), 4.96 (1H, d, J=2.0Hz), 6.61-6.66 (2H, m), 6.99 (1H, t, J=
7.6Hz),7.16-7.17(1H,m),7.19-7.24(3H,m),7.43-7.49(3H,m),7.56-7.60(1H,m),7.96-
7.98(2H,m);13C NMR(100MHz,CDCl3):δ26.0,30.2,52.6,56.1,62.6,66.1,102.2,108.3,
122.7,123.6,123.7,124.1,124.8,128.4,128.8,129.7,129.8,133.4,135.1,137.1,
142.0,142.7,144.3,145.4,169.8,175.6,176.0,191.2.HRMS(ESI-TOF)calcd.for
C30H24BrN2O5[M+H]+571.0863;found:571.0867.
Embodiment 23:
2- (1- methyl -3- tertiary butyloxycarbonyl oxygroups -2- the oxidations of 0.3mmol (104.1mg) are added in 2mL dichloromethane
Indoline -3- bases) methyl acrylate, the 1- methyl -3-[ of 0.2mmol (55.5mg);The Asias 2- oxos -2- (4- aminomethyl phenyls) second
Ji ]Indole-2-ketone and 12.4mg β -6'Hydroxyl cinchonicine, mixture stir 7 hours under 25 DEG C of reaction temperature,
Reaction process is monitored with thin-layered chromatography.After reaction carries out completely, mixture obtain through column chromatographic isolation and purification (C1R, C4R,
C5S)-3,3'-[1- (4- methyl benzoyls) Huan Wuxiji ]Adjoin double loop coil Oxoindole (yield 36%, dr values >99:1,
Ee values 95%).
(C1R,C4R,C5S)-3,3'-[1- (4- methyl benzoyls) Huan Wuxiji ]Adjoin the table of double loop coil Oxoindoles
Levy data:[α]D 25=-31.2 (c 0.50, CHCl3);mp 247.1-249.0℃.The ee was determined by
HPLC (Chiralpak AD-H, i-PrOH/hexane=30/70, flow rate 1.0mL/min, λ=254nm, major
diastereomer:tmajor=18.3min, tminor=26.0min)1H NMR(400MHz,CDCl3):δ2.40(3H,s),
2.99 (3H, s), 3.07 (3H, s), 3.63 (3H, s), 4.98 (1H, d, J=2.1Hz), 6.56 (2H, dd, J=7.7Hz,
4.2Hz), 6.79 (1H, t, J=7.6Hz), 6.95 (1H, t, J=7.6Hz), 7.10 (1H, t, J=7.8Hz), 7.12-7.13
(1H, m), 7.17 (1H, t, J=7.7Hz), 7.24-7.27 (3H, m), 7.50 (1H, d, J=7.5Hz), 7.89 (2H, d, J=
8.1Hz);13C NMR(100MHz,CDCl3):δ21.9,25.9,26.4,52.5,56.0,62.2,66.6,107.9,108.0,
122.4,122.5,124.1,124.6,125.2,125.3,129.2,129.3,129.4,130.0,134.7,143.1,
144.1,144.3,144.4,144.7,170.0,175.1,176.3,191.0.HRMS(ESI-TOF)calcd.for
C31H27N2O5[M+H]+507.1914;found:507.1921.
Embodiment 24:
2- (1- methyl -3- tertiary butyloxycarbonyl oxygroups -2- the oxidations of 0.3mmol (104.1mg) are added in 2mL dichloromethane
Indoline -3- bases) methyl acrylate, the 1- methyl -3-[ of 0.2mmol (58.3mg);2- oxos -2- (2,4- 3,5-dimethylphenyls) is sub-
Yi Ji ]Indole-2-ketone and 12.4mg β -6'Hydroxyl cinchonicine, it is small that mixture stirs 7 under 25 DEG C of reaction temperature
When, reaction process is monitored with thin-layered chromatography.After reaction carries out completely, mixture obtain through column chromatographic isolation and purification (C1R,
C4R,C5S)-3,3'-[1- (2,4- dimethylbenzoyls) Huan Wuxiji ]Adjoin double loop coil Oxoindole (yield 49%, dr
Value 97:3, ee value >99%).
(C1R,C4R,C5S)-3,3'-[1- (2,4- dimethylbenzoyls) Huan Wuxiji ]Adjoin double loop coil Oxoindoles
Characterize data:[α]D 25=-106.8 (c 1.00, CHCl3);mp 219.1-220.5℃.The ee was determined
By HPLC (Chiralpak AD-H, i-PrOH/hexane=30/70, flow rate 1.0mL/min, λ=254nm,
major diastereomer:tmajor=12.6min)1H NMR(400MHz,CDCl3):δ2.36(3H,s),2.38(3H,
S), 3.00 (3H, d, J=1.0Hz), 3.06 (3H, d, J=1.0Hz), 3.61 (3H, d, J=0.9Hz), 4.95 (1H, s),
6.57 (2H, d, J=7.8Hz), 6.85 (1H, t, J=7.6Hz), 6.96 (1H, t, J=7.6Hz), 7.01-7.03 (2H, m),
7.12 (2H, t, J=7.6Hz), 7.18 (1H, t, J=7.7Hz), 7.32 (1H, d, J=7.6Hz), 7.49 (1H, d, J=
7.6Hz), 7.87 (1H, d, J=7.7Hz);13C NMR(100MHz,CDCl3):δ20.6,21.6,25.9,26.4,52.5,
55.8,62.5,66.2,107.9,108.0,122.4,122.5,124.1,124.6,125.3,125.5,126.3,129.2,
129.3,131.7,132.3,134.5,138.7,142.0,144.4,144.6,144.9,145.5,169.9,175.0,
176.3,193.0.HRMS(ESI-TOF)calcd.for C32H29N2O5[M+H]+521.2071;found:521.2076.
Embodiment 25:
2- (1- methyl -3- tertiary butyloxycarbonyl oxygroups -2- the oxidations of 0.3mmol (104.1mg) are added in 2mL dichloromethane
Indoline -3- bases) methyl acrylate, the 1- methyl -3-[ of 0.2mmol (56.3mg);2- oxos -2- (4- fluorophenyls) Ya Yiji ]-
Indole-2-ketone and 12.4mg β -6'Hydroxyl cinchonicine, mixture stir 7 hours under 25 DEG C of reaction temperature, reaction
Process is monitored with thin-layered chromatography.After reaction carries out completely, mixture obtain through column chromatographic isolation and purification (C1R, C4R,
C5S)-3,3'-[1- (4- fluoro benzoyls) Huan Wuxiji ]Adjoin double loop coil Oxoindole (yield 69%, dr values >99:1, ee
Value >99%).
(C1R,C4R,C5S)-3,3'-[1- (4- fluoro benzoyls) Huan Wuxiji ]Adjoin the characterization of double loop coil Oxoindoles
Data:[α]D 25=-90.5 (c 1.00, CHCl3);mp 232.3-233.9℃.The ee was determined by
HPLC (Chiralpak AD-H, i-PrOH/hexane=30/70, flow rate 1.0mL/min, λ=254nm, major
diastereomer:tmajor=11.5min)1H NMR(400MHz,CDCl3):δ 3.03 (3H, s), 3.10 (3H, d, J=
0.7Hz), 3.67 (3H, s), 5.03 (1H, d, J=1.7Hz), 6.60 (2H, dd, J=7.7Hz, J=2.6Hz), 6.84 (1H,
T, J=7.6Hz), 6.99 (1H, t, J=7.6Hz), 7.12-7.23 (5H, m), 7.28 (1H, s), 7.52 (1H, d, J=
7.6Hz), 8.05 (2H, dd, J=8.1Hz, 5.7Hz);13C NMR(100MHz,CDCl3):δ25.9,26.4,52.6,56.0,
62.2,66.5,108.1 (1C, d, J=4.4Hz), 115.9 (1C, d, J=21.8Hz), 122.5,122.6,124.1,124.5,
125.0,125.1,129.3,129.4,132.4,132.5,133.6,142.8,144.4,144.7,144.8,166.0(1C,d,
), J=253.5Hz 169.9,174.9,176.3,189.9.HRMS (ESI-TOF) calcd.for C30H24FN2O5[M+H]+
511.1664;found:511.1672.
Embodiment 26:
2- (1- methyl -3- tertiary butyloxycarbonyl oxygroups -2- the oxidations of 0.3mmol (104.1mg) are added in 2mL dichloromethane
Indoline -3- bases) methyl acrylate, the 1- methyl -3-[ of 0.2mmol (59.5mg);2- oxos -2- (4- chlorphenyls) Ya Yiji ]-
Indole-2-ketone and 12.4mg β -6'Hydroxyl cinchonicine, mixture stir 7 hours under 25 DEG C of reaction temperature, reaction
Process is monitored with thin-layered chromatography.After reaction carries out completely, mixture obtain through column chromatographic isolation and purification (C1R, C4R,
C5S)-3,3'-[1- (4- chlorobenzene formacyls) Huan Wuxiji ]Adjoin double loop coil Oxoindole (yield 70%, dr values 97:3, ee values
>99%).
(C1R,C4R,C5S)-3,3'-[1- (4- chlorobenzene formacyls) Huan Wuxiji ]Adjoin the characterization of double loop coil Oxoindoles
Data:[α]D 25=-99.1 (c 1.00, CHCl3);mp 231.4-233.1℃.The ee was determined by
HPLC (Chiralpak AD-H, i-PrOH/hexane=30/70, flow rate 1.0mL/min, λ=254nm, major
diastereomer:tmajor=15.6min)1H NMR(400MHz,CDCl3):δ3.00(3H,s),3.07(3H,s),3.64
(3H, s), 4.99 (1H, d, J=2.0Hz), 6.56-6.58 (2H, m), 6.81 (1H, t, J=7.6Hz), 6.95 (1H, t, J=
7.6Hz), 7.09-7.14 (2H, m), 7.18 (1H, t, J=7.7Hz), 7.23 (1H, d, J=7.9Hz), 7.44 (2H, d, J=
8.4Hz), 7.48 (1H, d, J=7.6Hz), 7.93 (2H, d, J=8.3Hz);13C NMR(100MHz,CDCl3):δ26.0,
26.4,52.6,56.0,62.3,66.5,108.0,108.1,122.5,122.6,124.1,124.5,125.0,125.1,
129.1,129.4,131.3,135.6,139.8,142.8,144.4,144.7,145.2,169.8,174.9,176.3,
190.2.HRMS(ESI-TOF)calcd.for C30H24ClN2O5[M+H]+527.1368;found:527.1375.
Embodiment 27:
2- (1- methyl -3- tertiary butyloxycarbonyl oxygroups -2- the oxidations of 0.3mmol (104.1mg) are added in 2mL dichloromethane
Indoline -3- bases) methyl acrylate, the 1- methyl -3-[ of 0.2mmol (68.4mg);2- oxos -2- (4- bromophenyls) Ya Yiji ]-
Indole-2-ketone and 12.4mg β -6'Hydroxyl cinchonicine, mixture stir 7 hours under 25 DEG C of reaction temperature, reaction
Process is monitored with thin-layered chromatography.After reaction carries out completely, mixture obtain through column chromatographic isolation and purification (C1R, C4R,
C5S)-3,3'-[1- (4- benzoyl bromides) Huan Wuxiji ]Adjoin double loop coil Oxoindole (yield 50%, dr values 97:3, ee values
>99%).
(C1R,C4R,C5S)-3,3'-[1- (4- benzoyl bromides) Huan Wuxiji ]Adjoin the characterization of double loop coil Oxoindoles
Data:[α]D 25=-31.2 (c 1.00, CHCl3);mp 233.2-234.5℃.The ee was determined by
HPLC (Chiralpak AD-H, i-PrOH/hexane=30/70, flow rate 1.0mL/min, λ=254nm, major
diastereomer:tmajor=18.0min)1H NMR(400MHz,CDCl3):δ2.99(3H,s),3.05(3H,s),3.63
(3H, s), 4.99 (1H, s), 6.56 (2H, dd, J=7.6Hz, J=2.7Hz), 6.80 (1H, t, J=7.6Hz), 6.95 (1H,
T, J=7.6Hz), 7.08-7.19 (3H, m), 7.23 (1H, d, J=7.9Hz), 7.48 (1H, d, J=7.5Hz), 7.60 (2H,
D, J=8.3Hz), 7.84 (2H, d, J=8.2Hz);13C NMR(100MHz,CDCl3):δ25.9,26.4,52.6,56.0,
62.2,66.5,108.0,108.1,122.4,122.5,124.0,124.5,124.9,125.0,128.4,129.4,131.3,
132.0,135.9,142.7,144.3,144.7,145.2,169.7,174.8,176.2,190.3.HRMS(ESI-TOF)
calcd.for C30H24BrN2O5[M+H]+571.0870;found:571.0863.
Embodiment 28:
2- (1- methyl -3- tertiary butyloxycarbonyl oxygroups -2- the oxidations of 0.3mmol (104.1mg) are added in 2mL dichloromethane
Indoline -3- bases) methyl acrylate, the 1- methyl -3-[ of 0.2mmol (68.4mg);2- oxos -2- (1- naphthalenes) Ya Yiji ]- Yin
Diindyl quinoline -2- ketone and 12.4mg β -6'Hydroxyl cinchonicine, mixture stir 7 hours under 25 DEG C of reaction temperature, react into
Journey is monitored with thin-layered chromatography.After reaction carries out completely, mixture obtains (C1R, C4R, C5S)-through column chromatographic isolation and purification
3,3'-[1- (1- naphthoyls) Huan Wuxiji ]Adjoin double loop coil Oxoindole (yield 47%, dr values 96:4, ee values 85%).
(C1R,C4R,C5S)-3,3'-[1- (1- naphthoyls) Huan Wuxiji ]Adjoin the characterization number of double loop coil Oxoindoles
According to:[α]D 25=-4.8 (c 0.50, CHCl3);mp 232.8-234.1℃.The ee was determined by HPLC
(Chiralpak AD-H, i-PrOH/hexane=30/70, flow rate 1.0mL/min, λ=254nm, major
diastereomer:tmajor=20.3min, tminor=40.3min)1H NMR(400MHz,CDCl3):δ3.04(3H,s),
3.11 (3H, s), 3.67 (3H, s), 5.04 (1H, d, J=2.0Hz), 6.60 (2H, dd, J=7.7Hz, J=2.7Hz), 6.82
(1H, t, J=7.6Hz), 6.98 (1H, t, J=7.6Hz), 7.12 (1H, t, J=7.7Hz), 7.20 (1H, t, J=7.7Hz),
7.24-7.25 (1H, m), 7.33 (1H, d, J=7.5Hz), 7.53-7.56 (1H, m), 7.57-7.63 (2H, m), 7.85-7.90
(2H, m), 7.92-7.95 (1H, m), 8.10 (1H, d, J=7.5Hz), 8.65 (1H, s);13C NMR(100MHz,CDCl3):δ
25.8,25.9,26.3,26.4,51.9,52.6,55.4,55.6,62.9,63.0,65.9,66.1,107.8,107.9,
108.0,108.1,121.4,121.5,122.3,122.4,122.6,122.7,124.1,124.2,125.1,125.2,
125.3,125.6,125.8,126.2,129.3,129.4,129.5,134.7,135.4,144.1,144.2,144.3,
144.4,145.4,147.7,150.3,150.4,160.8,163.0,168.1,169.7,174.6,174.7,175.7,
175.8.HRMS(ESI-TOF)calcd.for C34H27N2O5[M+H]+543.1914;found:543.1923.
Embodiment 29:
2- (1- methyl -3- tertiary butyloxycarbonyl oxygroups -2- the oxidations of 0.3mmol (104.1mg) are added in 2mL dichloromethane
Indoline -3- bases) methyl acrylate, 4,7- dimethyl -3- (2- oxo -2- phenyl-ethylenes) benzene of 0.2mmol (55.7mg)
And (3H) -one of furans -2 and 12.4mg β -6'Hydroxyl cinchonicine, mixture stir 7 hours under 25 DEG C of reaction temperature,
Reaction process is monitored with thin-layered chromatography.After reaction carries out completely, mixture obtain through column chromatographic isolation and purification (C1R, C4R,
C5S)-3,3'-[1- (1- benzoyls) Huan Wuxiji ]Adjoin double loop coil Oxoindole (yield 47%, dr values >99:1, ee value >
99%).
(C1R,C4R,C5S)-3,3'-[1- (1- benzoyls) Huan Wuxiji ]Adjoin the characterization number of double loop coil Oxoindoles
According to:[α]D 25=130.5 (c 1.00, CHCl3);mp 175.8-176.7℃.The ee was determined by HPLC
(Chiralpak OD-H, i-PrOH/hexane=8/92, flow rate 0.8mL/min, λ=254nm, major
diastereomer:tmajor=25.8min)1H NMR(400MHz,CDCl3):δ1.95(3H,s),2.08(3H,s),2.93
(3H, s), 3.62 (3H, s), 4.77 (1H, d, J=2.0Hz), 6.56 (1H, d, J=7.8Hz), 6.61 (1H, d, J=
7.9Hz), 6.79 (1H, d, J=7.9Hz), 7.04 (1H, t, J=7.6Hz), 7.21-7.25 (1H, m), 7.29-7.30 (1H,
M), 7.44 (1H, d, J=7.6Hz), 7.51 (3H, t, J=7.7Hz), 7.59-7.63 (1H, m), 8.01 (1H, d, J=
8.2Hz);13C NMR(100MHz,CDCl3):δ14.5,19.3,26.1,52.6,54.7,62.2,68.9,108.0,117.6,
120.9,122.9,124.1,124.3,126.3,129.0,129.7,129.8,130.9,133.5,133.9,135.7,
140.0,144.4,145.9,152.4,169.6,174.3,176.2,190.0.HRMS(ESI-TOF)calcd.for
C31H26NO6[M+H]+508.1757;found:508.1759.
Claims (7)
1. one kind is with optical activation to adjoin double loop coil oxidized indole compounds, which is characterized in that have the following structure:
In formula:X is NR5, O or S substituent groups.
With optical activation adjoin double loop coil oxidized indole compounds 2. according to claim 1, which is characterized in that
Work as X=NR5When, R5Be each independently selected from H, Me, Et,nPr,nBu,iPr, allyl, Ph or Bn;
Correspondingly, R1It is each independently selected from H, 4-F, 4-Cl, 5-Me, 5-OMe, 5-F, 5-OCF3,5-Cl,5-Br,6-Cl,6-
Br,7-F,7-Cl,7-CF3Or 7-OCF3;
Correspondingly, R2Be each independently selected from H, Me, Et,nPr,nBu,iPr, allyl, Ph or Bn;
Correspondingly, R3Be each independently selected from Me, Et,nPr,iPr,nBu,iBu,tBu or Ph;
Correspondingly, R4It is each independently selected from H, 4-F, 4-Cl, 5-Me, 5-OMe, 5-F, 5-OCF3,5-Cl,5-Br,6-Cl,6-
Br,7-F,7-Cl,7-CF3Or 7-OCF3;
Correspondingly, R is each independently selected from Me, OMe, OEt, OiPr,OtBu, OPh, OBn, phenyl, methyl substituted-phenyl, methoxy
Base substituted-phenyl, fluorine substituted-phenyl, chlorine substituted-phenyl, bromine substituted-phenyl, 1- naphthalenes, 2- naphthalenes, 2- furyls or 2- thienyls.
With optical activation adjoin double loop coil oxidized indole compounds 3. according to claim 1, which is characterized in that
As X=O or S,
Correspondingly, R1It is each independently selected from H, 4-F, 4-Cl, 5-Me, 5-OMe, 5-F, 5-OCF3,5-Cl,5-Br,6-Cl,6-
Br,7-F,7-Cl,7-CF3Or 7-OCF3;
Correspondingly, R2Be each independently selected from H, Me, Et,nPr,nBu,iPr, allyl, Ph or Bn;
Correspondingly, R3Be each independently selected from Me, Et,nPr,iPr,nBu,iBu,tBu or Ph;
Correspondingly, R4It is each independently selected from H, 5-Me, 4,6-Me2,4,7-Me2,5-OMe,4,6-(OMe)2Or 4,7- (OMe)2;
Correspondingly, R is each independently selected from Me, OMe, OEt, OiPr,OtBu, OPh, OBn, phenyl, methyl substituted-phenyl, methoxy
Base substituted-phenyl, fluorine substituted-phenyl, chlorine substituted-phenyl, bromine substituted-phenyl, 1- naphthalenes, 2- naphthalenes, 2- furyls or 2- thienyls.
4. according to claims 1 to 3 it is any it is described it is with optical activation adjoin double loop coil oxidized indole compounds, it is special
Sign is, optics Chun Du≤85% with optical activation for adjoining double loop coil oxidized indole compounds.
With optical activation adjoin double loop coil oxidized indole compounds 5. according to claim 4, which is characterized in that
Optics Chun Du≤95% with optical activation for adjoining double loop coil oxidized indole compounds.
With optical activation adjoin double loop coil oxidized indole compounds 6. according to claim 4, which is characterized in that
Optics Chun Du≤98% with optical activation for adjoining double loop coil oxidized indole compounds.
7. pair loop coil oxidized indole compounds with optical activation that adjoin according to claim 4 are in antitumor activity
In application.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810391499.1A CN108690029B (en) | 2018-04-27 | 2018-04-27 | One kind is with optical activation to adjoin double loop coil oxidized indole compounds and its application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810391499.1A CN108690029B (en) | 2018-04-27 | 2018-04-27 | One kind is with optical activation to adjoin double loop coil oxidized indole compounds and its application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108690029A true CN108690029A (en) | 2018-10-23 |
CN108690029B CN108690029B (en) | 2019-12-03 |
Family
ID=63845847
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810391499.1A Expired - Fee Related CN108690029B (en) | 2018-04-27 | 2018-04-27 | One kind is with optical activation to adjoin double loop coil oxidized indole compounds and its application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108690029B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111892608A (en) * | 2020-08-27 | 2020-11-06 | 遵义医科大学 | Spiroheterocyclic 2, 3-dihydrobenzofuran compound with optical activity and application thereof |
CN111961060A (en) * | 2020-08-27 | 2020-11-20 | 遵义医科大学 | Preparation method of spiroheterocyclic 2, 3-dihydrobenzofuran compound with optical activity |
CN114886892A (en) * | 2022-05-07 | 2022-08-12 | 四川大学 | Application of oxindole spiro-bicyclo [2,2,1] heptane compounds in preparation of drugs for treating gastric cancer |
-
2018
- 2018-04-27 CN CN201810391499.1A patent/CN108690029B/en not_active Expired - Fee Related
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111892608A (en) * | 2020-08-27 | 2020-11-06 | 遵义医科大学 | Spiroheterocyclic 2, 3-dihydrobenzofuran compound with optical activity and application thereof |
CN111961060A (en) * | 2020-08-27 | 2020-11-20 | 遵义医科大学 | Preparation method of spiroheterocyclic 2, 3-dihydrobenzofuran compound with optical activity |
CN111892608B (en) * | 2020-08-27 | 2021-07-06 | 遵义医科大学 | Spiroheterocyclic 2, 3-dihydrobenzofuran compound with optical activity and application thereof |
CN114886892A (en) * | 2022-05-07 | 2022-08-12 | 四川大学 | Application of oxindole spiro-bicyclo [2,2,1] heptane compounds in preparation of drugs for treating gastric cancer |
CN114886892B (en) * | 2022-05-07 | 2023-09-12 | 四川大学 | Application of oxindole spiro [2, 1] heptane compounds in preparation of medicines for treating gastric cancer |
Also Published As
Publication number | Publication date |
---|---|
CN108690029B (en) | 2019-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108690029B (en) | One kind is with optical activation to adjoin double loop coil oxidized indole compounds and its application | |
Gao et al. | Efficient organocatalytic asymmetric synthesis of 2-amino-4H-chromene-3-carbonitrile derivatives | |
CN103865290B (en) | Fluorine boron fluorescence dye and its preparation method and application | |
CA2558051C (en) | Palladium catalyzed indolization of 2-bromo or chloroanilines | |
Thakur et al. | “On water” catalyst-free, column chromatography-free and atom economical protocol for highly diastereoselective synthesis of novel class of 3-substituted, 3-hydroxy-2-oxindole scaffolds at room temperature | |
CN110204487B (en) | Synthesis method of quinoline derivative | |
CN108440542B (en) | A kind of preparation method with optical activation for adjoining double loop coil oxidized indole compounds | |
Kouznetsov et al. | A simple entry to novel spiro dihydroquinoline-oxindoles using Povarov reaction between 3-N-aryliminoisatins and isoeugenol | |
Downer-Riley et al. | Iodine-mediated cyclisation of thiobenzamides to produce benzothiazoles and benzoxazoles | |
CN107162968A (en) | A kind of method of visible light catalytic Tetrahydroquinolinesas oxidative dehydrogenation synthesis of quinoline class compound | |
Shao et al. | The Cs2CO3–catalyzed reaction of 2-oxindoles with enones for the preparation of indolin-3-ones and their further transformation | |
Shaikh et al. | Synthesis, in vitro COX-1/COX-2 inhibition testing and molecular docking study of novel 1, 4-benzoxazine derivatives | |
CN110204491B (en) | Synthesis method of chiral 3, 4-dihydroisoquinolinone compound | |
Sun et al. | On-water silver (I)-catalyzed cycloisomerization of acetylenic free amines/amides towards 7-azaindole/indole/isoquinolone derivatives | |
CN110256444B (en) | Method for synthesizing benzimidazoloquinazolinone compound | |
CN105481752B (en) | A kind of preparation method of the trifluoromethyl oxidized indole compounds of 3 fluorine alkenyl Oxoindole spiral shell 3,3 ' | |
CN107266457A (en) | Ketone compounds of two indoline of a kind of 2,3 ' spiral shell 2 and preparation method thereof | |
CN105777781B (en) | Thiazole [4,5 e] thiophene [2,3 b] pyridine derivatives with fluorescent functional and preparation method thereof | |
Bernini et al. | 1, 2-Disubstituted 4-quinolones via copper-catalyzed cyclization of 1-(2-halophenyl)-2-en-3-amin-1-ones | |
CN108947945A (en) | A kind of 1,3- dihydroisobenzofuran derivative and its synthetic method and application | |
CN102105433B (en) | 6-nitro acetophenone compounds, preparation methods and uses thereof | |
CN104892485B (en) | 2 perfluoroalkyl indole derivativeses and its synthetic method | |
JP2019038987A (en) | Fluorescent dye agent and carbostyril compound | |
Granda et al. | Synthesis of 7-and 8-functionalized 2-aminophenoxazinones via cyclocondensation of 2-aminophenols | |
Enoua et al. | Syntheses and Fluorescent Properties of 6‐Methoxy‐2‐oxoquinoline‐3, 4‐dicarbonitriles and 6, 7‐Dimethoxy‐2‐oxoquinoline‐3, 4‐dicarbonitriles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 563000 Dalian Road, Guizhou, China, No. 201, No. Applicant after: ZUNYI MEDICAL University Address before: 563000 No. 201 Dalian Road, Huichuan District, Zunyi City, Guizhou Province Applicant before: ZUNYI MEDICAL University |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20191203 |